The Bionematicides Market was valued at US$ 613.05 million in 2025 and is projected to reach US$ 2,382.08 million by 2034, expanding at a CAGR of 16.28% during 2026–2034. Bionematicides—comprising beneficial microbial organisms like Bacillus firmus, Trichoderma species, and Purpureocillium lilacinum, alongside biochemical plant extracts—represent an essential biological tool...